“We will research, develop and make available commercially effective and affordable plant-based cannabinoid medicines specifically for treating patients suffering from cancer related pain in the UK.”
Graeme McFarlane, Chief Executive Officer
A diverse team with extensive experience in the pharmaceutical, regulation and finance sectors
A diverse team with extensive experience in the Canadian and Californian cannabis market, public company management, Agri-Tech and European pharmaceutical patient access.
